Literature DB >> 22658893

The revolving door between hospital and community: extended-spectrum beta-lactamase-producing Escherichia coli in Dublin.

L Burke1, H Humphreys, D Fitzgerald-Hughes.   

Abstract

BACKGROUND: Escherichia coli that produce extended-spectrum beta-lactamases (ESBLs) are an increasing cause of healthcare-associated infection, and community healthcare facilities may be a reservoir for important epidemic clones. AIM: To characterize retrospectively and investigate the epidemiology of ESBL-producing E. coli collected in a Dublin hospital, during 2009 and 2010, and to investigate the dissemination of specific clones within hospital and community healthcare facilities.
METHODS: Pulsed-field gel electrophoresis (PFGE) was used to determine the genetic relatedness of 100 ESBL-producing E. coli isolates. Phylogenetic groups were determined and the O25b-ST131 clone identified in the collection. The genetic data were correlated with antimicrobial susceptibility, clinical and demographic data to explore the epidemiology of specific clones.
FINDINGS: Phylogenetic groups B2 (62%) and D (18%) were the most common and were associated with non-urinary isolates (P<0.0001 by Fisher's exact test). PFGE revealed 12 clusters (≥ 80% similarity), the largest of which clustered with the epidemic UK strain A. Residents of long-term care facilities (LTCFs) in the community exclusively carried the O25b-ST131 clone and phylogenetic groups B2 and D.
CONCLUSIONS: E. coli O25b-ST131 is largely responsible for ESBL-producing E. coli in LTCFs in Dublin. The distribution of ESBL-producing E. coli in our hospital and community highlights a 'revolving door' through which these resistant bacteria spread and disseminate.
Copyright © 2012 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22658893     DOI: 10.1016/j.jhin.2012.04.021

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  15 in total

Review 1.  A new clone sweeps clean: the enigmatic emergence of Escherichia coli sequence type 131.

Authors:  Ritu Banerjee; James R Johnson
Journal:  Antimicrob Agents Chemother       Date:  2014-05-27       Impact factor: 5.191

2.  Colonisation with extended-spectrum beta-lactamase (ESBL) not detected in a prevalence study.

Authors:  C O'Connor; M G Kiernan; C Finnegan; J Powell; L Power; N H O'Connell; C P Dunne
Journal:  Ir J Med Sci       Date:  2016-09-24       Impact factor: 1.568

3.  Escherichia coli sequence type 131 is a dominant, antimicrobial-resistant clonal group associated with healthcare and elderly hosts.

Authors:  Ritu Banerjee; Brian Johnston; Christine Lohse; Stephen B Porter; Connie Clabots; James R Johnson
Journal:  Infect Control Hosp Epidemiol       Date:  2013-02-13       Impact factor: 3.254

4.  Who is leading this dance? Understanding the spread of Escherichia coli sequence type 131.

Authors:  Benjamin A Rogers; Yohei Doi
Journal:  Infect Control Hosp Epidemiol       Date:  2013-02-13       Impact factor: 3.254

5.  Incidence and Outcomes of Infections Caused by Multidrug-Resistant Enterobacteriaceae in Children, 2007-2015.

Authors:  Sharon B Meropol; Allison A Haupt; Sara M Debanne
Journal:  J Pediatric Infect Dis Soc       Date:  2018-02-19       Impact factor: 3.164

6.  Long-Term Care Facilities Are Reservoirs for Antimicrobial-Resistant Sequence Type 131 Escherichia coli.

Authors:  Mary J Burgess; James R Johnson; Stephen B Porter; Brian Johnston; Connie Clabots; Brian D Lahr; James R Uhl; Ritu Banerjee
Journal:  Open Forum Infect Dis       Date:  2015-02-17       Impact factor: 3.835

7.  Colonisation with ESBL-producing and carbapenemase-producing Enterobacteriaceae, vancomycin-resistant enterococci, and meticillin-resistant Staphylococcus aureus in a long-term care facility over one year.

Authors:  Catherine Ludden; Martin Cormican; Akke Vellinga; James R Johnson; Bernie Austin; Dearbháile Morris
Journal:  BMC Infect Dis       Date:  2015-04-01       Impact factor: 3.090

Review 8.  Epidemic potential of Escherichia coli ST131 and Klebsiella pneumoniae ST258: a systematic review and meta-analysis.

Authors:  M J D Dautzenberg; M R Haverkate; M J M Bonten; M C J Bootsma
Journal:  BMJ Open       Date:  2016-03-17       Impact factor: 2.692

9.  Implementation of an antimicrobial stewardship program targeting residents with urinary tract infections in three community long-term care facilities: a quasi-experimental study using time-series analysis.

Authors:  Sarah B Doernberg; Victoria Dudas; Kavita K Trivedi
Journal:  Antimicrob Resist Infect Control       Date:  2015-12-01       Impact factor: 4.887

Review 10.  Tackling Drug Resistant Infection Outbreaks of Global Pandemic Escherichia coli ST131 Using Evolutionary and Epidemiological Genomics.

Authors:  Tim Downing
Journal:  Microorganisms       Date:  2015-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.